Physician profile
Chloe Phillips
NPI 1528621612
$1,110.45
in general payments reported to CMS, 2019-2025
17 companies · $736 in 2025
The $736 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $110 · 2024: $264 · 2025: $736.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,097 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,097.10 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $226.47 | 2025 | Acessa Provu System, Myosure Tissue Removal Device |
| Astellas Pharma US INC | $211.56 | 2024-2025 | Veozah |
| Mayne Pharma Commercial LLC | $132.52 | 2023-2025 | |
| Evofem Biosciences, INC. | $81.35 | 2024-2025 | Phexxi, Solosec, Phexx |
| Exact Sciences Corporation | $80.74 | 2025 | The Cologuard Plus Collection Kit |
| Sage Therapeutics, LLC | $54.62 | 2024 | |
| Millicent US INC | $48.85 | 2023-2025 | Femring, Intrarosa, Femlyv |
| Bayer Healthcare Pharmaceuticals INC. | $45.00 | 2025 | |
| Organon LLC | $41.17 | 2024 | |
| Abbvie INC. | $32.99 | 2023 | |
| Merck Sharp & Dohme LLC | $30.57 | 2023-2024 | Gardasil 9, M-M-R II, Gardasil |
| Coopersurgical, INC. | $28.15 | 2024-2025 | Paragard T 380a |
| Meditrina | $22.40 | 2025 | |
| Exeltis, USA INC. | $20.66 | 2024 | Slynd |
| Mimedx Group, INC. | $19.64 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $17.00 | 2024 | Twirla |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.76 | 2025 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chloe Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.